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Ly49D-mediated cytokine and chemokine 
production from killing in primary natural 
killer cells
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and David M. Tarlinton
 
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia
 
Engagement of receptors on the surface of natural killer (NK) cells initiates a biochemical 
cascade ultimately triggering cytokine production and cytotoxicity, although the 
interrelationship between these two outcomes is currently unclear. In this study we 
investigate the role of the cell surface phosphatase CD45 in NK cell development and 
intracellular signaling from activating receptors. Stimulation via the major histocompatibility 
complex I–binding receptor, Ly49D on 
 
CD45
 
 
 
/
 
 
 
 primary NK cells resulted in the activation 
of phosphoinositide-3-kinase and normal cytotoxicity but failed to elicit a range of 
cytokines and chemokines. This blockage is associated with impaired phosphorylation of Syk, 
Vav1, JNK, and p38, which mimics data obtained using inhibitors of the src-family kinases 
(SFK). These data, supported by analogous findings after CD16 and NKG2D stimulation of 
 
CD45
 
 
 
/
 
 
 
 primary NK cells, place CD45 upstream of SFK in NK cells after stimulation via 
immunoreceptor tyrosine-based activation motif-containing receptors. Thus we identify 
CD45 as a pivotal enzyme in eliciting a precise subset of NK cell responses.
 
The activation of NK cells forms part of the
innate immune response to parasites, tumors,
and virally infected cells and is important for
their clearance (1). These responses are achieved
via intracellular signaling cascades emanating
from numerous activating receptors. For exam-
ple,  recognition of H-2d (2) or murine cy-
tomegalovirus (MCMV) encoded m157 (3) by
Ly49D and Ly49H respectively, results in cell-
mediated cytotoxicity and large scale produc-
tion of IFN-
 
 
 
 and, in response to MCMV in-
fection, chemokines such as MIP-1
 
 
 
, MIP-1
 
 
 
,
RANTES, and ATAC (4–7). Antibody bound
to soluble or membrane antigens can bind CD16
on NK cells leading to antibody-dependent cell
cytotoxicity (ADCC) and secretion of IFN-
 
 
 
and GM-CSF (8, 9). These activating recep-
tors do not contain intrinsic kinase activity,
but instead associate with transmembrane
adaptor molecules containing immunoreceptor
tyrosine-based activation motifs (ITAMs). NK
cells use three such ITAM adaptors; DAP12
homodimers required for Ly49D and Ly49H
signaling (10) and either homo- or het-
erodimers of Fc
 
 
 
RI
 
 
 
 and CD3
 
 
 
 for CD16
(11–13).
Whereas Ly49D, Ly49H, and CD16 only
associate with ITAM-containing adaptors,
NKG2D can signal through DAP12 (14–16)
in mouse (17) and DAP10 in both mouse and
human NK cells, which contains a YxxM
binding motif for the p85 subunit of phospho-
inositide-3-kinase (PI3K; 18). NKG2D is ex-
pressed on all NK cells and is capable of bind-
ing stress-induced ligands such as retinoid acid
early inducible transcript (Rae-1; 19). The as-
sociation of NKG2D with at least two distinct
adaptor proteins suggests it may activate dis-
tinct signal pathways that may result in distinct
cellular responses such cytokine/chemokine
production versus cytotoxicity. Indeed, analy-
sis of mice lacking key proximal signaling pro-
teins indicates such a bifurcation in signaling
may occur. Depending on their activation sta-
tus, both Syk
 
 
 
/
 
 
 
Zap70
 
 
 
/
 
 
 
 and DAP12
 
 
 
/
 
 
 
 NK
cells are capable of killing target cells via
NKG2D (20), yet have an abrogated IFN-
 
 
 
response to NKG2D stimulation (14). Fur-
thermore, DAP10 activation results in the
phosphorylation of PLC-
 
 
 
2 and Vav1 in NK
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cell lines whereas DAP12 recruitment leads to Syk, Zap70,
SLP76, and LAT phosphorylation (21). Thus recruitment of
either DAP12 or DAP10 appears to activate independent
biochemical pathways leading to distinct cellular responses,
although this has yet to be confirmed in primary cells.
The proximal signaling events leading to ITAM phos-
phorylation in NK cells are thought to involve the activation
of src-family kinase (SFK) members, which in NK cells in-
clude Lck, Fyn, Lyn, Fgr, and Yes (22), however only limited
evidence supports this role. Indeed, NK cells lacking Lck (23)
and Fyn (23, 24) appear grossly normal, although a role for
Fyn in the lysis of cells lacking MHC-I and NKG2D ligands
has been reported (25). The transmembrane protein tyrosine
phosphatase CD45 is expressed on all hematopoietic cells in-
cluding NK cells and appears to function by dephosphorylat-
ing the COOH-terminal tyrosine of SFKs, leading to a con-
formation that favors autophosphorylation of the catalytic
tyrosine (26–28). Indeed lymphocytes lacking CD45 show
significant hyporesponsiveness to antigen receptor cross-link-
ing attributed to a failure to appropriately activate SFK (29).
Early studies into the role of CD45 in NK cell function used
various CD45-deficient NK cell lines or antibodies (30, 31).
However, the generation 
 
CD45
 
 
 
/
 
 
 
 mice demonstrated that
in contrast to cell lines, primary 
 
CD45
 
 
 
/
 
 
 
 NK cells are capa-
ble of normal natural killing (32). To date, studies in primary
 
CD45
 
 
 
/
 
 
 
 NK cells have not addressed the function of CD45
in the biochemical signal cascade emanating from activating
NK cell receptors. Given the role of CD45 in regulating SFK
activity and the proposed importance of SFK in NK cell re-
ceptor signaling, we investigated the regulation of primary
NK cell signaling pathways in the absence of CD45. We find
CD45 to be required for the full activation of Syk, Vav1, and
calcium release, and in phosphorylation of JNK and p38 after
ITAM activation. The failure to activate these signaling inter-
mediates in 
 
CD45
 
 
 
/
 
 
 
 NK cells is associated with dramatically
impaired cytokine and chemokine production. In contrast,
CD45 is dispensable for ITAM-mediated PI3K activity and
DAP10-mediated cytotoxicity, establishing a potential di-
chotomy in signals required for primary NK cell cytotoxicity
versus cytokine production.
 
RESULTS
CD45 is required for normal NK cell development
 
Mice with a targeted disruption of exon-6 in the CD45 gene
have been previously shown to have enhanced number of
splenic NK cells (32), however, it is unclear how this arises.
We investigated the development and phenotype of NK
cells from mice with a targeted disruption of 
 
CD45
 
 exon-
12 (33). These mice (hereafter referred to as 
 
CD45
 
 
 
/
 
 
 
)
had a four- and fivefold increase in the percentage of
NK1.1
 
 
 
CD49b
 
 
 
TCR-
 
 
 
 
 
 NK cells in the spleen and liver,
respectively (Fig. 1 A). This increased percentage equates to
significantly enhanced numbers of NK1.1
 
 
 
CD49b
 
 
 
TCR-
 
 
 
 
 
cells in 
 
CD45
 
 
 
/
 
 
 
 mice with 19 
 
 
 
 2 
 
  
 
10
 
6
 
 and 1.3 
 
 
 
 0.2 
 
 
 
10
 
6
 
 NK cells in the spleen and liver, respectively, compared
with 2.4 
 
 
 
 0.3 
 
  
 
10
 
6
 
 and 2 
 
 
 
 0.4 
 
  
 
10
 
5
 
 (P 
 
 
 
 0.05; 
 
n
 
 
 
 
 
 8)
in control mice. This enhanced NK cellularity is unlikely to
result from increased production in BM as the percentage of
NK precursors (CD122
 
 
 
NK1.1
 
 
 
DX5
 
 
 
CD3
 
 
 
CD19
 
 
 
) (34)
was unchanged (Fig. 1 A) and no difference was observed in
bromodeoxyuridine (BrdU) uptake by BM NK1.1
 
 
 
CD49b
 
 
 
cells (Fig. 1 B). We did observe however, greater turnover of
NK cells in the spleen (P 
 
 
 
 0.008), but normal turnover in
the liver (Fig. 1 B). These findings indicate that the increased
number of NK cells in the spleen of 
 
CD45
 
 
 
/
 
 
 
 mice results
from enhanced peripheral expansion. Given that enhanced
Figure 1. The absence of CD45 alters NK cell development. (A) Spleen 
and liver from CD45 /  mice were analyzed for NK1.1 CD49b  NK cells by 
flow cytometry. NK cell precursors from bone marrow were identified as 
CD122 NK1.1 DX5 CD3 CD19 . Data are representative of 12 mice or 
6 mice for precursor analysis with percentages displayed next to each 
population. (B) Mice were given drinking water containing BrdU for 2 wk. 
Cells were stained with the same antibodies as in A with the addition anti-
BrdU and analyzed by flow cytometry. Percentages of divided cells (BrdU ) 
are shown above the each population, with CD45 /  spleen-derived NK 
cells having a greater percentage of dividing cells (*, P   0.008). Data are 
representative of three independent experiments. (C) Hematopoietic chi-
meras were generated by injecting irradiated Ly5.1 mice with equal amounts 
of control (Ly5.2) and CD45 /  bone marrow. The resulting NK1.1 DX5  
population was analyzed for expression of Ly5.2 by flow cytometry to 
deduce donor origin. (D) The level of Ly49D, CD244, and CD16 protein 
expression on the surface of freshly isolated and IL-15–expanded 
NK1.1 CD49b  cells was analyzed by flow cytometry. Data shown for C 
and D are representative of six independent experiments. 
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NK cell turnover in 
 
CD45
 
 
 
/
 
 
 
 mice appears to occur only in
the spleen and may reflect a consequence of the CD45-defi-
cient environment, we prepared mixed hematopoietic chi-
meras. The NK cells in the spleen of the chimeras were
mostly of 
 
CD45
 
 
 
/
 
 
 
 origin (80% Ly5
 
 
 
) indicating the in-
creased in vivo production is intrinsic to 
 
CD45
 
 
 
/
 
 
 
 NK cells
(Fig. 1 C), consistent with a previous report (32). We next
examined whether CD45 was required for normal matura-
tion by examining cells for the acquisition of activating and
inhibitory receptors. We observed a significantly reduced
proportion of NK1.1
 
 
 
DX5
 
 
 
 cells expressing the activating
receptor Ly49D (P 
 
 
 
 0.043) in both the spleen and liver of
 
CD45
 
 
 
/
 
 
 
 mice (Table I; and unpublished data). The acquisi-
tion of other Ly49 receptors and CD94-NKG2A/C/E and
NKG2D, thought to occur before the expansion stage in NK
development (35), was not significantly affected by the ab-
sence of CD45. All receptors expressed on 
 
CD45
 
 
 
/
 
 
 
 NK
cells were at equivalent levels to controls except for a signifi-
cant down-regulation of the activating receptor CD244 (P 
 
 
 
0.001), a phenotype that is stable in mixed chimeras (unpub-
lished data). Interestingly, in vitro expansion of 
 
CD45
 
 
 
/
 
 
 
NK cells using IL-15 returned CD244 expression and the
percentage of Ly49D
 
 
 
 NK cells to levels equivalent to con-
trols (Fig. 1 D and unpublished data).
 
Normal growth of CD45
 
 
 
/
 
 
 
 NK cells in response to 
IL15 and IL21
 
CD45 and the SFK have been implicated as positive and
negative regulators of cytokine responses in multiple cell
types (27), prompting us to investigate the cytokine respon-
siveness of 
 
CD45
 
 
 
/
 
 
 
 NK cells. We observed 
 
CD45
 
 
 
/
 
 
 
 NK
cells to proliferate normally across a range of IL-15 concen-
trations and different time points in tissue culture (Fig. 2, A
and B). We recently showed that IL-21 functionally differ-
entiates NK cells both in vivo and in vitro (36). IL-21 was
able to slow IL-15–mediated division in both control and
CD45
 
 
 
/
 
 
 
 NK cells (Fig. 2 B) and further differentiate these
cells as characterized by a down-regulation of NK1.1 (Fig. 2
C) and the acquisition of a larger, more granular phenotype
and reduced viability (unpublished data). Taken together,
these data show CD45 not to be required for IL-15 and IL-
21 responsiveness, and that the cells derived from these cul-
tures are indistinguishable by phenotype from controls.
 
CD45 is essential for cytokine production after ITAM-
containing receptor activation
 
An important cellular response triggered by activating recep-
tors on NK cells is the production of cytokines. To deter-
mine if CD45 is required for cytokine production, IL-15–
 
Table I. 
 
Phenotype of CD45
 
 
 
/
 
 
 
 NK cells
 
Marker
Surface expression in vivo
CD45
 
 
 
/
 
 
 
CD45
 
 
 
/
 
 
 
% positive
CD122 90.4   0.9 88.4   1.4
Ly49A 13.0   0.5 11.6   0.8
Ly49C/I 42.2   6.5 37.2   1.2
Ly49D 45.0   3.0 32.4   4.3a
Ly49G2 39.4   1.1 39.4   2.7
Ly49H 47.6   2.8 44.6   3.3
Ly49F 98.4   0.8 10.0   1.3
CD49b 100   0.0 100   0.0
Fc RII 98.0   1.3 99.2   0.6
CD43 83.4   7.9 93.7   2.0
MAC-1 93.7   1.5 94.0   6.7
CD94 43.2   1.5 57.4   6.7
NKG2A/C/E 41.8   0.9 49.2   3.4
NKG2D 100   0.0 100   0.0
2B4 96.4   1.1 61.4   2.8a
NK1.1 100   0.0 100   0.0
NK1.1 DX5  splenocytes from CD45 /  and CD45 /  mice analyzed for the 
expression of surface markers. Values indicate the mean   SEM percentages of NK 
cells deemed positive by flow cytometry from six mice per group. 
aP   0.045 by Student’s t test.
Figure 2. In vitro expansion of NK cells. (A) CD45 /  and control 
NK1.1 CD49b TCR-   cells were sorted and cultured in various concentra-
tions of IL-15 for 60 h. Cultures were pulsed with [3H]thymidine for the final 
8 h and radioactive incorporation counted. (B) CD45 /  and control 
NK1.1 CD49b TCR-   cells were cultured for 48 or 72 h in 50 ng/ml IL-15 
with or without 100 ng/ml IL-21. Cultures were pulsed with [3H]thymidine for 
the final 8 h and radio-labeled DNA counted. For A and B data are represen-
tative of four independent experiments. (C) Cells cultured in IL-15 with or 
without IL-21 for 72 h were analyzed for surface expression levels of NK1.1 
by flow cytometry. Data are representative of three independent experiments.CD45 REGULATES NK CELL CYTOKINE PRODUCTION | Huntington et al. 1424
expanded NK cells were cultured overnight in the presence
of plate-bound mAbs. We found CD45 to be critical for the
production of IFN-  after ligation of the ITAM-containing
receptors Ly49D, NKG2D, and CD16 (P   0.039) but not
NK1.1 or the IL-12 and IL-18 receptors (Fig. 3 A). Interest-
ingly, inhibitors of SFK (PP2 and SU6656) mimicked these
results (P   0.04; Fig. 3 B and unpublished data) suggesting
a role for CD45 in the activation of these kinases in NK
cells, whereas inhibitors of the PI3K pathway (Wortmannin
and Ly294002) had little effect on IFN-  production (un-
published data). Stimulation of mouse NK cells by coculture
with CHO cells is predominantly through Ly49D recogni-
tion (37), and this also failed to elicit IFN-  from CD45 / 
NK cells at ratios of 1:10 and 1:1 for 24 h (Fig. 3 C). CD16
stimulation of control NK cells induced GM-CSF, which
was significantly impaired in the absence of CD45 (P  
0.0004; Fig. 3 D) or after treatment of control cells with PP2
(P   0.0003; Fig. 3 E). We also measured these parameters
using freshly isolated NK1.1 CD49b TCR-   cells and
found that while cytokine production was reduced across all
stimuli compared with in vitro expanded cells, CD45 / 
NK cells still secreted vastly less cytokine compared with
control cells (Fig. 3 F). Collectively these data highlight the
critical requirement for SFK activation and CD45 in cyto-
kine production after ITAM receptor stimulation.
CD45 is essential for chemokine production via ITAM-
containing receptors
NK cells are a potent source of inflammatory chemokines
such as RANTES, MIP-1 , and MIP-1  (6, 38). These are
critical for recruiting effector cells to the site of antigen chal-
lenge thus aiding in the clearance of pathogens. Ly49D liga-
Figure 3. CD45 is required for ITAM-mediated cytokine production. 
(A) IL-15–expanded CD45 /  and control NK1.1 CD49b TCR-   cells 
were cultured for 24 h in the presence of plate-bound mAbs against 
NK1.1, Ly49D, CD16, NKG2D, or soluble IL-12 and IL-18. Culture superna-
tants were assayed for IFN-  by ELISA. Data shown are the average of five 
independent experiments (*, P   0.039). (B) Cells were cultured as in A ex-
cept for a 30-min preincubation with the SFK inhibitor PP2. DMSO (carrier) 
or PP3 were used as controls. 5 and 10  M PP2 both inhibited Ly49D and 
CD16-mediated IFN-  production without affecting production via NK1.1. 
Data are representative of three independent experiments (*, P   0.045). 
(C) NK cells were cultured with CHO cells at ratios of 1:1 and 1:10. Data 
are representative of two independent experiments (*, P   0.05). (D) IL-15–
expanded CD45 /  and control NK cells were cultured for 24 h in the pres-
ence of plate-bound anti-CD16. Supernatants were assayed for GM-CSF by 
ELISA. Data from three independent experiments are shown (*, P   0.0004). 
(E) NK cells treated as in C were cultured for 24 h in the presence of 
plate-bound anti-CD16. Supernatants were assayed for GM-CSF by ELISA 
(*, P   0.0003). Data are representative of three independent experiments. 
(F) Freshly isolated NK1.1 CD49b TCR-   cells were cultured for 24 h in 
the presence of plate-bound mAbs against NK1.1, Ly49D, and CD16. Cul-
ture supernatants were assayed for IFN-  by ELISA. Data shown are the 
average of two independent experiments (*, P   0.04).JEM VOL. 201, May 2, 2005 1425
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tion on NK cells has been shown to result in the robust pro-
duction of MIP-1  and MIP-1  (38) Ly49D-stimulated
CD45 /  NK cells produced between 100- and 1,000-fold
less MIP-1  (P   0.0001) and MIP-1  (P   0.0002) than
control NK cells (Fig. 4 A). Furthermore, the T cell and
monocyte attractant RANTES was also abundantly pro-
duced by NK cells after Ly49D ligation and this also dis-
played an essential requirement for CD45 (P   0.0002; Fig.
4 B). The role of CD45 in this process appears to be the ac-
tivation of the SFK because inhibition of SFK activity by
PP2 induced the same phenotype, blocking the production
of MIP-1  (P   0.0005), MIP-1  (P   0.0025), and
RANTES (P   0.01; Fig. 4 C). Taken together, these find-
ings identify CD45 and the SFK as critical signaling mole-
cules in the production of chemokines from NK cells.
Natural cytotoxicity is independent of CD45
CD45-exon 6–deficient mice were previously shown to
have normal cytotoxicity against YAC-1 cells (32), which
are recognized via NKG2D. To address whether CD45 / 
NK cells could also kill non-NKG2D target cells, we tested
their ability to lyse a range of targets. As expected CD45 / 
NK cells efficiently lysed NKG2D ligand  target cells in-
cluding YAC-1 and RMA-S Rae1b. Interestingly, control
and  CD45 /  NK cells were equally efficient at killing
CHO cells, a process predominantly mediated through
Ly49D (37; Fig. 5, A and B). These data suggest that unlike
cytokine production, cytotoxicity triggered via Ly49D and
NKG2D is CD45-independent. The MHC class I–deficient
cell line RMA-S was killed more efficiently than MHC class
I expressing RMA cells by NK cells from both knockout
and control mice, indicating that NK inhibitory receptor
signaling is intact in the absence of CD45. IL-21 enhanced
control and CD45 /  NK cell killing against all targets to a
similar degree, supporting the independence of IL-21 signal-
ing and CD45 (Fig. 2).
As cytokine production after ITAM-containing receptor
ligation was dependent on CD45, we investigated whether
these same receptors could participate in redirected cytolysis
of FcR  P815 cells, a process known to be Syk/Zap70 de-
pendent (20). IL-15–activated control and CD45 /  NK
cells displayed equal basal killing and both responded to
ITAM-dependent Ly49D and CD16 engagement with in-
creased killing, most notably at an E/T ratio of 27:1 (Fig. 5
C). It is possible that the initial in vitro expansion in IL-15
altered the activation status of the cells and may therefore
not accurately represent the requirement for these ITAM
signaling molecules for in vivo lysis. We addressed this issue
in a nonmanipulated setting by addressing in vivo killing us-
ing BM allograft rejection, whereby BALB/c BM (H-2d)
was transferred into irradiated control or CD45 /  B6 (H-2b)
mice. Antibody depletion studies have previously shown
that H-2d rejection is dependent on Ly49D  NK cells (39).
We observed that both C57BL/6 and CD45 /  mice pos-
sessed significantly fewer splenic colonies when H-2d BM
grafts are transferred compared with isogenic H-2b BM
grafts (P   0.01; Fig. 5 D) indicating that rejection of H-2d
BM by Ly49D  NK cells occurs independently of CD45.
Similarly CHO killing is only slightly impaired when NK
cells are treated with PP2 (Fig. 5 E), whereas PI3K inhibitors
have a much greater effect on lysis supporting the notion
that Ly49D-mediated lysis is independent of CD45 and
SFKs. Taken together, these findings demonstrate that both
Figure 4. Ly49D-mediated chemokine production requires CD45. 
(A) IL-15–expanded CD45 /  and control NK1.1 CD49b TCR-   cells were 
cultured for 24 h in the presence of plate-bound anti-Ly49D. Culture super-
natants were assayed for MIP-1  (*, P   0.000027) and –1  (**, P   0.00014) 
by ELISA. Data from five independent experiments are shown. (B) NK cells were 
treated with a titration of PP2 and cultured for 24 h in the presence of plate-
bound anti-Ly49D. Supernatants were assayed for MIP-1  (*, P   0.00044) 
and –1  (**, P  0.0025) by ELISA. Statistics are for 10  M PP2 treatment. 
Data shown are representative of three independent experiments. (C) IL-15–
expanded CD45 / , control and PP2-treated NK1.1 CD49b TCR-   cells 
were cultured for 24 h in the presence of plate-bound anti-Ly49D. Superna-
tants were assayed for RANTES (*, P   0.00013; **, P   0.01) by ELISA. Data 
are the average of four independent experiments.CD45 REGULATES NK CELL CYTOKINE PRODUCTION | Huntington et al. 1426
in vivo and in vitro natural cytotoxicity of a variety of targets
by NK cells occurs independently of CD45. The increased
number of NK cells in CD45 /  mice may alter the E/T ra-
tio in vivo, masking potential differences in killing effi-
ciency. However, since CD45-deficient mice have substan-
tially greater spleen mass (unpublished data), target cell
numbers may also be elevated, making accurate in vivo E/T
calculations difficult.
Optimal activation of Syk after ITAM-containing receptor 
triggering requires CD45
As some NK cell functions were impaired after Ly49D and
CD16 activation in the absence of CD45, we investigated
signal propagation in these cells. The total tyrosine phosphor-
ylation (Fig. 6 A) differed considerably between CD45 / 
and control IL-15–expanded NK cells. We note the virtual
absence of phosphoproteins of around 95 and 105 kD in size
and a dramatic reduction of a phosphorylated band at  50-
kD protein in the absence of CD45 (Fig. 6 A). Furthermore,
in contrast to controls, Ly49D stimulation failed to increase
phosphorylation of 97-, 68-, and 58-kD proteins in CD45 / 
NK cells. As protein tyrosine phosphorylation was not en-
hanced in CD45 /  NK cells we assessed the activation status
of Syk, it being the dominant Ly49D/DAP12-induced pro-
tein tyrosine kinase (PTK) in NK cells (21, 40). Consistent
with earlier studies (40), Ly49D stimulation of control NK
cells induced a large increase in phosphorylated Syk after 10
min (Fig. 6 B). However, very little phosphorylated Syk was
detected in lysates from equivalently treated CD45 /  NK
cells (Fig. 6 B). CD16 stimulation similarly failed to activate
Figure 5. NK cytotoxicity in the absence of CD45. (A) IL-15–expanded 
CD45 /  and control NK1.1 CD49b TCR-   cells were cultured for 6 d in 
the presence or absence of IL-21 on the final day and assessed for their 
ability to lyse the indicated target cells in a 4-h 51Cr release assay. Data 
shown are the mean   SEM of triplicates from one of three independent 
experiments. (B) Freshly sorted NK1.1 CD49b TCR-   cells were used in a 
4-h 51Cr release assay targeting CHO or RMA-S Rae1  cells. Data shown 
are the mean   SEM of triplicates from one of three independent experi-
ments. (C) IL-15–expanded CD45 /  and control NK cells were cultured for 
6 d and then stimulated with soluble mAb against NK1.1, Ly49D, and 
CD16. They were then tested for their ability to lyse P815 (FcR ) cells in a 
4-h 51Cr release assay. Data shown are the average mean   SEM of three 
independent experiments. (D) Control or CD45 /  mice (H-2b) were irradi-
ated and injected i.v. with either matched (H-2b) or mismatched (H-2d) 
bone marrow (BM) to assess their NK cells’ ability to kill foreign cells. 
Spleens were removed at day 8 and colonies (CFU-S) on the spleen surface 
enumerated. Both control and CD45 /  mice receiving H-2d BM had sig-
nificantly fewer splenic colonies compared with mice receiving H-2b BM 
(*, P   0.013). Data shown are the average mean   SEM of four (H-2b) 
and eight (H-2d) mice of each genotype. (E) NK cells were treated with PP2 
or Ly294002 and subjected to a 4-h 51Cr release assay targeting CHO cells. 
Data shown is representative of two independent experiments.JEM VOL. 201, May 2, 2005 1427
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Syk in CD45 /  NK cells (unpublished data) suggesting a
general role for CD45 in activating Syk after ITAM activa-
tion in NK cells. Zap70 is also expressed in NK cells however
its role in Ly49D signaling is largely unexplored. We found
that unlike Syk, phosphorylation of Zap70 was not enhanced
by Ly49D ligation in both control and CD45 /  NK cells
(Fig. 6 C). This was not due to inefficient stimulation, as ty-
rosine phosphorylation of a number of other proteins was in-
duced when whole cell lysates were examined. Ly49D stimu-
lation is known to activate PLC 1 resulting in an increase of
intracellular calcium (40). We observed such calcium flux in
control NK cells after Ly49D stimulation but saw no
change in the intracellular calcium level in identically treated
CD45 /  NK cells (Fig. 6 D). CD45 /  NK cells were ca-
pable of releasing calcium after ionomycin treatment, indicat-
ing that the defect in CD45 /  NK cells was specific for the
Ly49D pathway (Fig. 6 E). These finding show CD45 is es-
sential for full Syk phosphorylation and calcium flux after ac-
tivation of ITAM-containing receptors.
The absence of CD45 impairs MAPK activation in primary 
NK cells
CD16 stimulation of human NK cells results in SFK- and
Syk-dependent p38 phosphorylation and enhances cytotox-
Figure 6. Requirement of CD45 in Ly49D-dependent Syk activa-
tion in NK cells. IL-15–expanded CD45 /  and control NK cells were 
starved of cytokine and serum for 2 h and then stimulated with anti-
Ly49D mAb at 37 C for the indicated times. (A) Whole cell lysates were 
probed with anti-phosphotyrosine or with protein loading verified using 
anti– -actin. (B) Syk or (C) Zap70 were immunoprecipitated from Ly49D-
stimulated CD45 /  and control NK cell lysates and probed for antiphos-
photyrosine and anti-Syk or anti-Zap70 to determine protein loading. 
(D) IL-15–expanded CD45 /  and control NK cells were loaded with 
Indo-1-AM and stained with biotinylated anti-Ly49D. The ratio of fluorescence 
detected in FL5–FL4 was monitored by flow cytometry for 5 min with the 
addition of avidin to cross-link Ly49D receptors at 30 s. Data are a repre-
sentative of at least two independent experiments. (E) Indo-1-AM–loaded 
NK cells were treated with a calcium ionophore at 30 s. Changes in fluo-
rescence were monitored for 4 min. Data are a representative of at least 
two independent experiments.
Figure 7. CD45 and Vav1-independent PI3K activation in 
Ly49D-stimulated NK cells. IL-15–expanded CD45 /  and control 
NK1.1 CD49b TCR-   cells were starved of cytokine and serum for 2 h 
and then stimulated with anti-Ly49D mAb and anti-NK1.1 at 37 C for the 
indicated times. Whole cell lysates were probed with (A) anti–phospho-Akt 
and Akt or (B) anti–phospho-p38, anti–phospho-JNK, and anti– -actin. 
(C) Vav1 was immunoprecipitated from Ly49D-stimulated CD45 /  and con-
trol NK1.1 CD49b TCR-   cell lysates and probed for antiphosphotyrosine 
and anti-Vav1 to determine protein loading. Film developed from Vav1 blot 
was subjected to densitometry to determine the increase in phospho-Vav1 
after stimulation. Values are represented as ratios of indicated sample to 
unstimulated control cells. One of two experiments is shown.CD45 REGULATES NK CELL CYTOKINE PRODUCTION | Huntington et al. 1428
icity and IFN-  mRNA accumulation, processes that are
sensitive to inhibition of MAPK p38 (41, 42). Furthermore,
c-Jun NH2-terminal kinase (JNK) is phosphorylated after
NK cell interaction with immune complexes (42) and is also
strongly implicated in coupling surface receptor induced sig-
nals to IFN-  production in T cells (43, 44). To investigate
whether the impaired ITAM-mediated IFN-  production in
CD45 /  NK cells was associated with reduced activity of
the MAPKs, we assessed the phosphorylation state of p38
and JNK after Ly49D ligation. Indeed, CD45 /  NK cells
showed reduced phosphorylation of p38 after a 2- and 10-
min stimulation with impaired JNK phosphorylation ob-
served at 10 min, confirming that Syk is important in cou-
pling surface receptor signals to the activation of JNK and
p38 (Fig. 7 A). Interestingly, despite inducing IFN-  and
augmenting lysis of P815 cells, NK1.1 stimulation did not
activate p38, raising the possibility that p38 is specifically
downstream of ITAM-containing receptors in primary NK
cells. Analysis of MAPK-Erk1/2 phosphorylation was also
performed and whereas total Erk1/2 was readily observed in
primary NK cells, we were unable to detect phosphorylation
of these proteins after Ly49D stimulation (unpublished data).
Ly49D activates PI3K but not Vav1 in CD45 /  
primary NK cells
The ability of Ly49D on CD45 /  NK cells to recognize
and lyse CHO cells implies that Ly49D/DAP12 stimulation
activates signaling proteins required for cytolysis. Pharmaco-
logical studies have highlighted the importance of the PI3K
pathway in natural killing (14, 20, 45) and that this pathway
can be activated in an ITAM-independent manner (10, 18).
To assess whether the PI3K pathway is activated after
Ly49D/DAP12 stimulation, we measured the level of phos-
pho-Akt in lysates of Ly49D-stimulated NK cells. We ob-
served a striking increase in phospho-Akt after 10 min of
Ly49D stimulation in both control and CD45 /  NK cells
(Fig. 7 B). This finding suggests that, like the NKG2D path-
way, Ly49D may also activate the PI3K pathway and that
Akt is less reliant than MAPK JNK/p38 on CD45-mediated
SFK and Syk activity for phosphorylation after Ly49D stim-
ulation. The guanine nucleotide exchange factor Vav1 is also
implicated in natural cytotoxicity, as it is phosphorylated af-
ter both CD16 and NKG2D-DAP10 stimulation (21) and
Vav1 /  NK cells have reduced natural cytotoxicity against
NKG2D-ligand  target cells (46, 47). We found levels of
phospho-Vav1 to be increased after Ly49D stimulation of
control NK cells but almost undetectable in CD45 /  NK
cells irrespective of stimulation (Fig. 7 C). Consistent with
CD45 mediating its effects through the SFK, control NK
cells treated with PP2 not only failed to increase Vav1 phos-
phorylation after stimulation, but actually showed decreased
levels of phospho-Vav1 compared with untreated NK cells
(Fig. 7 C). Taken together, CD45 appears to be differentially
required for the optimal activity of signaling molecules
downstream of Ly49D, with normal Akt phosphorylation
being observed in the presence of impaired Syk, Vav1, and
p38 and JNK phosphorylation in CD45-deficient NK cells.
DISCUSSION
Differential requirement of CD45 in NK cell 
effector functions
This study has identified CD45 as pivotal in signal transduc-
tion from a prototypic ITAM-containing receptor on NK
cells, determining distinct functional outcomes from similar
ligand interactions. We show for the first time in NK cells
that modulation of a cell surface molecule can determine the
nature of the response. CD45 /  NK cells fail to produce
IFN- , GM-CSF, MIP-1 / , and RANTES when ITAM-
containing surface receptors are stimulated, a process that
normally results in robust production of these soluble factors.
Another cellular consequence from engagement of Ly49D
on NK cells is the release of lytic granules capable of killing
engaged cells. In contrast to cytokine production, NK cells
devoid of CD45 efficiently killed cells expressing ligands for
Ly49D. The ability of SFK inhibitors to block cytokine/
chemokine production from CD16-, NKG2D-, or Ly49D-
stimulated NK cells but only minimally effect cytotoxicity
mimics the CD45-null phenotype and strongly suggests that
CD45 lies upstream of the SFK and that its activity is differ-
entially required for Ly49D responses. Furthermore, the im-
paired Ly49D- and CD16-mediated phosphorylation of Syk
in CD45 /  NK cells suggests that CD45-mediated SFK ac-
tivity is important for the recruitment of Syk to phosphory-
lated ITAMs and/or the phosphorylation of recruited Syk.
An important question from our findings is how does en-
gagement of the same receptor lead to a bifurcation of sig-
naling pathways that differ in the requirement for CD45?
Signaling requirements for cytokine production
The failure of CD45 /  NK cells to secrete IFN-  after
CD16, NKG2D, or Ly49D stimulation is consistent with
the phenotype of Syk / /Zap70 /  mice (14, 20) and with
the pharmacological inhibitors of Syk being able to impair
Ly49D-mediated IFN-  production (38). Impaired Syk ac-
tivity in Ly49D-stimulated CD45 /  NK cells coincides
with hypophosphorylation of Vav1 and JNK and a failure
to release intracellular calcium. The involvement of Vav1
in this process, however, is unclear as CD16-mediated
IFN-  production has previously been shown to occur in-
dependently of Vav1 (46). In contrast, calcium and JNK are
likely to be involved in this process. Augmented IFN- 
production by T cells after CD158j ligation strongly corre-
lated with increased phospho-JNK (44), while exogenous
HIV-1 Tat, which blocks calcium influx can inhibit the
production of IFN-  after interactions with dendritic cells
(48). These findings define a signal transduction pathway
showing absolute dependence on CD45-SFK-Syk activity
for cytokine production from ITAM-containing receptors
(Fig. 8 A), raising the question of how cytotoxicity is dif-
ferentially regulated.JEM VOL. 201, May 2, 2005 1429
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Same receptor, different pathway—signaling for cytotoxicity
Signal transduction pathways leading to cytotoxicity have
been defined in NK cells to some extent. It is clear for exam-
ple that killing through the Ly49D receptor requires activa-
tion of Syk/Zap70 as mice deficient in both fail to lyse CHO
cells (20). Similarly, DAP12-deficient NK cells fail to induce
cytotoxicity after Ly49H-mediated recognition of m157-
expressing cells (3) and analysis of NK cell lines has shown
DAP12 to activate the PI3K pathway in a Syk-dependent
manner (49). Although there is some evidence that Zap70 can
compensate for an absent Syk (50), the presence of a nonfunc-
tional Syk is dominant, suggesting that Zap70 normally has
little role in the induction of cytotoxicity (21, 40). We noted
an equal increase in phospho-Akt, a direct product of PI3K
activation, in Ly49D-stimulated CD45 /  NK cell lysates
compared with control lysates. This finding identifies for the
first time that Ly49D activates the PI3K pathway in primary
NK cells and that this signaling pathway can function inde-
pendently of CD45 and in the absence of normal levels of Syk
activity (Fig. 8 A). Interestingly, Ly49D-mediated IFN- 
production has been shown to be sensitive to pharmacological
inhibitors of PI3K, Syk, and SFK (38) suggesting that multiple
pathways contribute to IFN-  production after Ly49D stimu-
lation. Even though our findings support roles for Syk and
SFK activity in IFN-  production, we failed to find any evi-
dence for PI3K involvement in this process. The basis of this
difference is currently unclear but may reflect differences in
the derivation of the NK cells or the assay conditions.
Whereas it is apparent that cytotoxicity after NKG2D li-
gation requires PI3K recruitment to the YxxM motif of
DAP10 (21) and activation, processes which occur indepen-
dently of Syk and Zap70 (21) and calcium release (15),
DAP10 is not recruited to Ly49D after its ligation (10, 18, 51)
and is therefore an unlikely mediator of the resultant cytotox-
icity. It is, however, interesting to note that both NKG2D/
DAP10 (18) and Ly49D/DAP12 activate PI3K, placing this
lipid kinase centrally to both cytotoxic signaling pathways.
Recently, DAP12-mediated cytotoxicity in contrast to
NKG2D/DAP10-mediated killing was shown to be largely
Vav independent (47). Our data support the notion that
Vav1 is not required for DAP12-mediated CHO lysis, and
suggest that Syk lies upstream of Vav1. We have not ad-
dressed the phosphorylation state of Vav1 after NKG2D li-
gation, although recent findings (47) would predict it to be
normal since CD45 /  NK cells efficiently kill YAC-1 and
RMA-S Rae1  cells.
It is puzzling to note that although both DAP12 and
DAP10 appear to require tyrosine phosphorylation for the
recruitment and activation of kinases (21, 40, 52), only
DAP12-mediated pathways appear affected in CD45 /  NK
cells with DAP10-mediated killing intact, a phenotype also
seen in the Syk/Zap70 /  mice. Furthermore, the intact
NKG2D-mediated killing by primary CD45 /  and Syk/
Zap70 /  NK cells contrasts with their failure to secrete
IFN-  via NKG2D stimulation and suggests that the re-
quirement of SFKs and Syk in DAP10 phosphorylation is
less stringent than that of DAP12. The finding that PP2
treatment only mildly affects YAC-1 killing (20) supports
this. Furthermore, it appears that cytotoxicity is only com-
pletely blocked if PI3K, SFK, and Syk are inactivated in
Figure 8. A model of CD45-dependent and -independent NK cell signaling. (A) Engagement of the ITAM-recruiting receptor, Ly49D results in 
various responses that are differentially regulated by CD45. Cytokine signaling and cytotoxicity are functional in CD45 /  NK cells. In contrast cytokine 
and chemokine production are absolutely dependent on CD45, most likely through its activation of SFKs and full activation of Syk, ultimately leading to 
calcium release and the activation of MAPK family members. (B) The level of Ly49D-mediated Syk/Zap70 activity controls NK cell responses with full 
activity (WT) required for cytokine production and cytotoxicity via this receptor. Reduced activity (CD45 / ) correlates with blocked cytokine production, 
whereas no activity (Syk/Zap70 / ) also blocks Ly49D-mediated killing.CD45 REGULATES NK CELL CYTOKINE PRODUCTION | Huntington et al. 1430
combination (20), highlighting the importance of natural
killing and thus the numerous mechanisms leading to its trig-
gering. Collectively this evidence suggests a signaling cascade
after Ly49D ligation that involves PI3K but is distinct from
the DAP10-mediated pathway, which can function inde-
pendently of Syk/Zap70 (20).
The level of Syk activity differentially activates distinct 
signaling pathways
Our observation that CD45 /  NK cells differentially acti-
vate cytotoxicity and cytokine production after stimulation
through prototypical ITAM-containing receptors adds signif-
icantly to the understanding of these phenomenon by associ-
ating this dichotomy with discrete changes in the activity of
signaling molecules. These results suggest two possible mod-
els for the induction of effector functions after ITAM recep-
tor stimulation. In one there is a bifurcation of signaling with
one pathway running through PI3K to cytotoxicity and the
second through Vav1/Ca2 /JNK to cytokine production.
The alternative proposal is that cytotoxicity and cytokine
production are triggered at different signaling thresholds.
Ly49D can stimulate the phosphorylation of Akt, a criti-
cal substrate in cytotoxicity (16, 20, 45), with this pathway
showing an absolute requirement for Syk/Zap70 (20). Re-
duced Ly49D-mediated phospho-Syk and basal phospho-
Zap70 in CD45 /  NK cells does not affect the efficiency of
CHO killing, supporting the notion that the small amount of
PTK activity in CD45 /  NK cells, as apposed to none in
Syk / /Zap70 /  cells, is above the threshold necessary to
activate cytolysis but not cytokine production (Fig. 8 B). It is
also possible that the numerous receptor interactions between
an NK cell and its target may activate Syk in a CD45-inde-
pendent manner. These more extensive interactions may also
induce Ca2  flux in CD45 /  NK cells, thereby fulfilling the
apparent requirement for Ca2  in killing (53). The failure of
Ly49D mAb to induce Erk1/2 phosphorylation, whereas NK
cells incubated with CHO cells displayed an increase in
Erk1/2 phosphorylation (47), may support this notion. We
have shown that Ly49D ligation activates Syk in a manner
that is largely CD45 dependent, but have yet to examine the
activation of Syk in the context of cell–cell interactions.
CD45 in NK cell development and cytokine signaling
CD45 is essential for B and T cell antigen receptor signaling,
development and maturation (26). However this is not the
case for NK cells. Peripheral expansion of CD45 /  NK cells
was enhanced in vivo, a phenomenon specific to the spleen,
cell intrinsic and independent of IL-15 responsiveness. Fur-
thermore, CD45 /  NK cells express all the surface receptors
characteristic of full maturation (35). The reduced percentage
of Ly49D  NK cells in vivo was particularly interesting since
this occurs in Syk / /Zap70 /  mice (20) and suggests that
CD45 activation of SFK and Syk may be involved in positive
signaling through Ly49D influencing the survival or selection
of Ly49D  cells in vivo. CD45 has also been identified as a
Jak phosphatase implicated in the negative regulation of cyto-
kine signaling (54). The normal response of CD45 /  NK
cells to IL-15, -12, -18, and -21 in vitro excludes cytokine
hyperresponsiveness as an contributing factor in the enhanced
NK cellularity in CD45 /  mice.
Our findings suggest a model of the biochemical path-
ways activated in NK cells after interactions between ligands
such as H-2d, m157, Rae1 , and Ig-Fc fragments and
ITAM-containing receptors such as Ly49D, Ly49H,
NKG2D, and CD16 (Fig. 8 A). Upon ligand binding, recep-
tors are drawn together recruiting ITAM-containing adaptor
molecules such as DAP12. CD45 then activates the SFKs al-
lowing phosphorylation of the ITAM and the recruitment of
PTKs (Syk/Zap-70) via their SH2 domain binding to phos-
phorylated ITAM, where they may be phosphorylated by
the SFKs. Syk can now activate Vav1 and signaling pathways
required for the production of cytokines/chemokines in-
cluding the release of calcium and the activation of the
MAPKs, JNK, and p38. In contrast, PI3K activation after
ITAM phosphorylation requires only a small enhancement
of Syk/Zap70 activity and is responsible for NK cell cyto-
toxicity. This model postulates segregated signaling pathways
dictated by their dependence on CD45-SFK–mediated acti-
vation of Syk with the production of cytokines/chemokines
absolutely dependent on CD45. In contrast cytotoxicity is
functional in the absence of CD45. This finding has impor-
tant implication for NK cell effector functions during devel-
opment and differentiation, as CD45 expression on NK cells
appears to change depending on maturation and activation
state of the cell (32). Furthermore, it may be possible to reg-
ulate these functions specifically by targeting CD45 on the
surface of NK cells.
MATERIALS AND METHODS
Mice. C57BL/6 and CD45 /  (gift from Dr. V. Tybulewicz (National In-
stitute for Medical Research, Mill Hill, UK; reference 33) mice were bred
and maintained at The Walter and Eliza Hall Institute of Medical Research.
CD45 mutation was backcrossed at least eight times onto the C57BL/6 back-
ground before being made homozygous and maintained by brother–sister
mating. All mice were used between 8 and 20 wk of age. Competitive BM
chimeras were generated by i.v. transfer of 2   106 CD45 /  and C57BL/6
bone marrow cells to C57BL/6 recipients after two doses of irradiation at 5.5
Gy. Animal experimentation was in strict accordance with protocols ap-
proved by the Royal Melbourne Hospital Animal Ethics Committee.
Antibodies, flow cytometry, and cell sorting. Antibodies specific for
NK1.1 (PK136), Ly49A (YE132), Ly49C/I (SW5E6), Ly49D (4E5/E1),
Ly49G2 (4D11), CD16 (24G.2), B220 (RA3-6B2), Ly5.2 (ALI 4A2), Ly5.1
(A20.1), CD3 (KT3-1.1), CD11b (Mac-1; M1/70), Gr-1 (RB6-8C5),
TCR-  (H57-5921), IFN-  (HB170 and XMG1.2), GM-CSF (MP1-22E9
and MP1-31G6), and IL-10 (JES5-2A5.1) were prepared as described previ-
ously (36). Antibodies against CD94 (18d3), DX5, NKG2A/C/E (20d5),
NKG2D (CX5), CD244 (SW2B4), Ly49F (HBF-719), CD8 (56–7.3),
BrdU (B44), CD122 (TM-1), IL-10 (SXC-1), and CD49b (HM2) were
purchased from (BD Biosciences). Anti-Ly49H (3D10) (55) was a gift
from Dr. A. Scalzo (University of Western Australia, Nedlands, Australia).
Antibodies used in immunoblot analysis and immunoprecipitation were;
anti-phosphotyrosine and anti-Akt (Upstate Biotechnology); anti-Vav1
(blotting), anti-actin, and anti-Syk (Santa Cruz Biotechnology, Inc.); anti–JEM VOL. 201, May 2, 2005 1431
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phospho-P44/42 MAPK (Thr202/Tyr204), anti–phospho-Akt (Ser473),
anti-Vav1 (IP), anti–phospho-P38 (Thr180/Try182), anti-P38, anti–Zap-70
(blotting), anti–phospho-Jnk (Thr183/Tyr185), and anti-JNK (Cell Signal-
ing Technology); anti–phospho-Src (Tyr418; Biosource); anti–Zap-70 (IP;
Caltag Laboratories); anti–rabbit-HRP, anti–goat HRP (Silenus); anti–
mouse IgG1, -2b, and -  (Southern Biotechnology Associates, Inc.). Single
cell suspensions were prepared by forcing organs through metal sieves. Liver
lymphocytes were isolated from a 40–80% Percoll gradient (Amersham Bio-
sciences) centrifuged for 20 min at 2,500 rpm. For flow cytometry, single-
cell suspensions were stained with the appropriate mAb in PBS containing
2% FCS. Biotinylated mAb were revealed by Cy5- or PE-streptavidin
(Southern Biotechnology Associates, Inc.). Cells were analyzed on an LSR
(BD Biosciences) with dead cells being excluded by propidium iodide stain-
ing. Cell sorting was performed using FacsDIVA (BD Biosciences) or MO-
FLO (Cytomation) to  98% purity.
NK cell in vitro function. Sorted NK cells were cultured in NunclonTM
six-well flat bottom tissue culture plates (Nunc) at 106 cells/ml in IMDM
supplemented with 10% FCS and 50 ng/ml Gentamycin (Sigma-Aldrich).
Cells were typically expanded for 5–7 d in 50 ng/ml recombinant human
IL-15 (R&D Systems). For cytokine/chemokine production, MULTI-
WELLTM 48-well tissue culture plates (BD Labware) were coated with 20
 g/ml of the indicated mAb overnight in PBS at 4 C. NK cells were
washed extensively and cultured for 24 h at 105 cells/well in 0.5 ml of
IMDM with 10% FCS. For NK–CHO cocultures, 5   104 purified NK
cells were incubated overnight with either 5   104 or 5   105 CHO cells.
Supernatants from 5   105 CHO cells culture alone were used as negative
controls. Cytokines used included: IL-12 (2 ng/ml), IL-18 (10 ng/ml), and
IL-21 (100 ng/ml; all from R&D Systems). IFN-  and IL-10 production
was determined by ELISA as described previously (36). GM-CSF was de-
tected by sandwich ELISA using MP1-22E9 as a capture Ab and MP1-
31G6-biotin as a detection Ab. RANTES, MIP-1 , and -  Quantikine kits
(R&D Systems) were used according to the manufacturer’s instructions.
Cell proliferation was performed by culturing 5   104 cells/well in 96-well,
flat-bottom plates with a titration of IL-15 (0.5–50 ng/ml) for 48 h with or
without IL-21. Plates were then pulsed with 1  Ci of [3H]thymidine (NEN
Life Science Products) and harvested after 8 h onto glass fiber filters (Pack-
ard instrument Co.) and incorporation was determined by scintillation
counting. The cytotoxicity of freshly isolated and in vitro expanded NK
cells were measured using a 4-h 51Cr-release assay described previously (56).
The YAC-1, CHO, P185, RMA, RMA-S, and RMA-S-Rae1  tumor cell
lines were loaded with 200  Ci of 51Cr (ICN Pharmaceutical). Reverse
ADCC assays were performed exactly as described previously (20). The
pharmacological inhibitors PP2, Ly294002, and SU6656 (Calbiochem)
were solubilized in DMSO and incubated with NK cells for 30 min at 37 C
before culturing. PP3 and DMSO were used as controls.
NK functions measured in vivo. Rejection of mismatched BM were
performed by i.v injection of 2   106 BALB/c (H-2d) or 105 C57Bl/6
(H-2b) BM cells in PBS into recipients after two doses of 5.5 Gy. After 8 d,
spleens were harvested and colonies counted using a dissecting microscope.
NK cell turnover was measured by addition of 0.5 mg/ml of BrdU (Sigma-
Aldrich) and 2% glucose to drinking water. After 2 wk, organs were har-
vested, single cell suspensions prepared, stained with mAb directed against
cell surface proteins, and fixed as described previously (57). Cells were then
resuspended in 50  g/ml Dnase1 (Sigma-Aldrich) in PBS, 1 mM CaCl2,
and 1 mM MgSO4 for 30 min at 37 C before being stained with anti-BrdU.
NK cell activation and immunoprecipitation. IL-15–cultured NK
cells (2–5   107) were washed resuspended in PBS/1% FCS. Cells were
stained with biotinylated mAbs for 15 min on ice, washed, stimulated with
20  g/ml avidin, and lysed using RIPA buffer. Cell lysates or precipitated
proteins were processed as described previously (58). Samples were sepa-
rated using 4–20% and 8% gels (Gradipore) and transferred to nitrocellulose
membranes (Amersham Pharmacia Biotech). Filters were probe with pri-
mary antibody overnight at 4 C, extensively washed, and revealed by incu-
bation with secondary Abs for 30 min. Blots were developed using Super-
Signal ECL reagent (Pierce Chemical Co.). Ca2  release was assessed by
loading IL-15–expanded NK cells with indo-1 acetoxymethyl (Molecular
Probes) as described previously (59). Loaded cells were stained with biotin-
ylated anti-Ly49D in the presence 2.4G2 to prevent FcR binding. After
washing, 2   106 cells were sampled using a LSR (BD Biosciences) for 30 s
to establish baseline fluorescence then avidin was added to 20  g/ml and
the analysis continued for 5 min.
Statistical analysis. Data were analyzed with Microsoft Excel software
applying the two-tailed Student’s t test. The null hypothesis was rejected
and differences deemed significant when P   0.05.
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